Dr Ellen Strahlman is SVP and the Chief Medical Officer for GSK.
Prior to joining GSK in August 2008, Ellen was Vice President, Worldwide Business Development at Pfizer. She joined the company in 2005 as the Vice President and Worldwide Therapeutic Area Head for Ophthalmology at Pfizer, Inc. Previously, Ellen worked at Bausch & Lomb, Merck & Co and, more recently, at Novartis and Virgoen Ltd.
Throughout her career, Ellen has been a champion and spokesperson for public health and world heath issues, including HIV. She is a graduate of Harvard University (Biochemical Sciences and Applied Mathematics) and obtained her medical degree from the Johns Hopkins School of Medicine. She has medical qualifications in general surgery and ophthalmology, together with a Masters Degree in Health Sciences.